| RYVAX | VENAX | RYVAX / VENAX | |
| Total Expense Ratio | 1.63 | 0.09 | 1,811% |
| Annual Report Gross Expense Ratio | 1.68 | 0.09 | 1,867% |
| Fund Existence | 28 years | 22 years | - |
| Gain YTD | 48.656 | 24.495 | 199% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 100000 | 3% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 50.6M | 11.8B | 0% |
| Annual Yield % from dividends | 0.41 | 2.47 | 16% |
| Returns for 1 year | 73.90 | 27.08 | 273% |
| Returns for 3 years | 61.14 | 39.80 | 154% |
| Returns for 5 years | 76.34 | 108.02 | 71% |
| Returns for 10 years | -25.67 | 67.53 | -38% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| USLUX | 21.50 | 0.03 | +0.14% |
| US Global Investors Global Luxury Goods | |||
| ICEWX | 54.29 | 0.01 | +0.02% |
| NYLI Epoch International Choice Class C | |||
| CWVGX | 27.01 | N/A | N/A |
| Calvert International Equity A | |||
| CDOYX | 47.58 | N/A | N/A |
| Columbia Dividend Opportunity Inst3 | |||
| VSCAX | 32.81 | -0.51 | -1.53% |
| Invesco Small Cap Value A | |||